This article first appeared on GuruFocus .
-
Revenue (Q4 2025):677 million SEK, 31% year-on-year growth adjusted for currency effects.
-
Organic Growth (Q4 2025):27%.
-
EBIT (Q4 2025):103 million SEK, including non-recurring costs of 17 million SEK.
-
EBIT Margin (Q4 2025):15.2%.
-
Gross Margin (Q4 2025):69%, a decrease of 1.1 percentage points.
-
Net Income (Q4 2025):Basic earnings per share of 0.72 SEK.
-
Revenue (Full Year 2025):2.467 billion SEK, 34% growth excluding currency effects.
-
EBIT (Full Year 2025):254 million SEK, margin of 10.3%.
-
Cash Flow (Q4 2025):Positive 46 million SEK after continuous investment.
-
Cash at Hand (End of Q4 2025):195 million SEK.
-
Net Debt (End of Q4 2025):909 million SEK.
-
Net Debt/EBITDA (Last 12 Months):1.7 times.
Release Date: February 05, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Dynavox Group AB ( TDVXF ) reported a strong revenue growth of 31% in Q4 2025, adjusted for currency effects, marking a continuation of a robust growth trajectory over the past four years.
-
The company saw robust growth across all geographies and markets, with significant demand for their solutions, particularly in the touch control product portfolio for younger users with autism and eye gaze-controlled solutions for users with complex needs.
-
The EBIT for Q4 2025 was 103 million SEK, indicating strong underlying profitability despite non-recurring costs.
-
Dynavox Group AB ( TDVXF ) expanded its market presence by acquiring its Italian reseller partner SR Labs Healthcare, enhancing its direct market presence.
-
The company successfully launched a new ERP system in North America, which is expected to provide a modern, digitalized, and scalable backbone for future operations.
Negative Points
-
Currency fluctuations had a negative impact on revenue, with a 15% negative effect reported in Q4 2025.
-
The gross margin decreased by 1.1 percentage points in Q4 2025, partly due to currency fluctuations and increased costs.
-
Non-recurring costs related to restructuring and investments in new systems totaled approximately 100 million SEK for the year, impacting profitability.
-
The company's operations were affected by macroeconomic factors, including the strengthening of the SEK against the US dollar, which posed headwinds on revenue and earnings.
-
Despite strong growth, the company faces tougher comparables going forward, which may challenge sustaining the current growth momentum.
Q & A Highlights
Q: Given the strong momentum in Q4, do you still see the potential to sustain a 20% plus organic growth rate despite tougher comparables? A: Fredrik Ruben, CEO: We acknowledge the tougher comparables but remain confident in our long-term predictions. We believe in an annual growth of 20% adjusted for currencies and contributions from acquisitions, and we are not making any changes to this outlook.
Q: Can you elaborate on the development and efficiency of your US Salesforce over the past year? A: Linda Tybring, CFO: We've added more personnel to our sales organization, improving efficiency. The sales team grew by about 20%, and we are seeing a positive trajectory in sales efficiency, which is encouraging given the recent additions.
Q: With the stronger profitability, how do you plan to use your balance sheet moving forward? A: Linda Tybring, CFO: We prioritize future investments and ensure we have excess cash for strategic opportunities. Given our business model, maintaining a certain leverage is appropriate, and we are confident in our current leverage levels.
Q: How are RAM memory prices impacting your gross margin and ability to deliver? A: Fredrik Ruben, CEO: While memory prices have increased, we use lower-spec memory chips, and the cost impact on our gross margin is minimal. Our gross margin remains strong at around 70%, so the effect is negligible.
Q: Have US reimbursement rates increased for 2026, and how does this affect your business? A: Linda Tybring, CFO: Yes, there is a 1.9% increase in reimbursement rates, which we will implement throughout the year. This increase is typically associated with inflation and underscores the stability of our reimbursement environment.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
